<DOC>
	<DOCNO>NCT02149901</DOCNO>
	<brief_summary>The specific aim study determine whether water ingestion potentiate pressor response pseudoephedrine patient primary disorder autonomic failure . The study design enable u also evaluate pressor response water alone pseudoephedrine alone . In secondary analysis , compare result patient two autonomic disorder , pure autonomic failure ( PAF ) multiple system atrophy ( MSA ) . We hypothesize drink water follow dose pseudoephedrine lead great increase blood pressure pseudoephedrine alone .</brief_summary>
	<brief_title>Water Sudafed Autonomic Failure</brief_title>
	<detailed_description>The maximal pressor response water reach pressor agent begin act . In addition therapeutic value water ingestion alone , blood pressure-raising effect agent increase sympathetic nervous system tone , phenylpropanolamine , potentiated water drinking . These drug interaction effect exploit treatment orthostatic hypotension combination water sympathomimetic potentially able increase blood pressure great extent long period time either water medication alone . However , interaction also lead potentially dangerous blood pressure surge . This protocol require initial screen history physical study participant , include safety lab EKGs , evaluation autonomic nervous system status follow consent process . If patient meet study criterion willing undergo study test , 4-way crossover protocol follow . Study Testing day 1 2 Arm 1 : Pseudoephedrine 30 mg PO + 50 ml water Arm 2 : Pseudoephedrine 30 mg PO + 480 ml water - Testing performed time day study , least 2 hour meal avoid confounding effect postprandial hypotension . - A saline lock insert blood sample least 30 minute baseline data collection . - Participants ask empty bladder begin test avoid effect full urinary bladder peripheral sympathetic activity . - Participants seat comfortably chair . They ask remain seated position duration study . - The Dinamap electrocardiographic blood pressure ( brachial cuff ) recorder attach patient set measurement every 5 minute throughout study digital download ADC ( Autonomic Dysfunction Center ) BP database . - Participants also instrument EKG , finger cuff sensor continuous monitoring blood pressure , heart rate , respiration , SpO2 , stroke volume , systemic vascular resistance , cardiac output , use Nexfin system Ivy Biomedical Vital-Guard monitor . - After 30 minute baseline monitoring period ( time -30 min 0 min ) , 4 ½ teaspoon blood collect osmolality measurement assay hormone regulate blood pressure . - The subject give 30 mg pseudoephedrine PO ( time 0 min ) . Monitoring continue 45 minute . - At 45 minute , participant ask drink 50 ml ( Arm 1 ) 480 ml ( Arm 2 ) water . - Additional blood sample ( 4 ½ teaspoon ) osmolality BP-regulating hormone collect 30 60 minute water ( +75 +105 minute study ) . - Monitoring continue + 135 min . - At 135 minute , study end day . The timing pseudoephedrine administration relative water ingestion duration monitor period base previous results3 pharmacokinetic data7 report Tmax pseudoephedrine 1 2 hour . Testing study day 2 identical participant consume alternate water volume . Study Testing day 3 4 optional Arm 3 : Placebo PO + 50 ml water Arm 4 : Placebo PO + 480 ml water Testing perform accord schedule Arms 1 2 . Instrumentation limit Dinamap electrocardiographic blood pressure ( brachial cuff ) recorder set measurement every 5 minute throughout study Arms 3 4 .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Shy-Drager Syndrome</mesh_term>
	<mesh_term>Pure Autonomic Failure</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<criteria>Age 1880 year , Neurogenic orthostatic hypotension , ≥30 mmHg drop SBP within 5 minute stand , Associated impair autonomic reflex , determine absence blood pressure overshoot phase IV valsalva maneuver , Absence identifiable cause autonomic neuropathy , Able willing provide inform consent Exclusion Criteria Pregnancy Current smoke habit Systemic illness know produce autonomic neuropathy , include limited diabetes mellitus , amyloidosis , monoclonal gammopathy unknown significance , autoimmune neuropathy . Known intolerance pseudoephedrine Preexisting sustain severe hypertension ( BP &gt; 180/110 mmHg sit position ) Clinically unstable coronary artery disease major cardiovascular neurological event past 6 month . Any significant systemic , hepatic , cardiac renal illness Use MAOI ( i.e . selegiline ; rasagiline Azilect , linezolid others ) within 14 day Known closedangle glaucoma Clinically meaningful arrhythmias Other factor investigator 's opinion would prevent participant complete protocol , include poor compliance previous study unpredictable schedule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pure Autonomic Failure</keyword>
	<keyword>Multiple System Atrophy</keyword>
	<keyword>Pseudoephedrine</keyword>
	<keyword>Water</keyword>
	<keyword>Osmopressor</keyword>
</DOC>